Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanan Zheng

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic ModelsRené Bruno, Dean Bottino, Dinesh P de Alwis, et al.
The AAPS Journal|October 14, 2025
Integrated Population Pharmacokinetic-pharmacodynamic Modeling of HIV Virus-host Infection Dynamics in Patients Undergoing Antiretroviral MonotherapyAlberto Vegas Rodriguez, Nieves Velez de Mendizábal, Yanan Zheng, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2013
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroidsMichael Noonan, Phillip Korenblat, Sofia Mosesova, et al.
Pulmonary Pharmacology & Therapeutics|August 28, 2017
Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthmaRui Zhu, Yanan Zheng, Nathanael L Dirks, et al.
Molecular Medicine (Cambridge, Mass.)|May 14, 2025
Targeting GPR84 to alleviate acute immune-mediated liver injuryYanan Zheng, Yumeng Wang, Yujie Xu, et al.
Cell Death & Disease|April 4, 2025
RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitinationChen Lu, Hongda Liu, Tianyu Liu, et al.
Cell Death Discovery|March 1, 2024
AIM2 regulates autophagy to mitigate oxidative stress in aged mice with acute liver injuryChao Hu, Mengjing Li, Yongzhen Chen, et al.
Eclinicalmedicine|November 3, 2025
Neoadjuvant FLOT versus SOX chemotherapy in locally advanced gastric cancer: secondary outcomes of a single-centre, open-label, randomised, exploratory phase 2 trialBirendra Kumar Sah, Zhenjia Yu, Benyan Zhang, et al.
Clinical Pharmacokinetics|January 20, 2012
A guide to rational dosing of monoclonal antibodiesShuang Bai, Karin Jorga, Yan Xin, et al.
Frontiers in Oncology|March 14, 2022
CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant ChemotherapyYong Chen, Wei Xu, Yan-Ling Li, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic ModelsRené Bruno, Dean Bottino, Dinesh P de Alwis, et al.
The AAPS Journal|October 14, 2025
Integrated Population Pharmacokinetic-pharmacodynamic Modeling of HIV Virus-host Infection Dynamics in Patients Undergoing Antiretroviral MonotherapyAlberto Vegas Rodriguez, Nieves Velez de Mendizábal, Yanan Zheng, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2013
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroidsMichael Noonan, Phillip Korenblat, Sofia Mosesova, et al.
Pulmonary Pharmacology & Therapeutics|August 28, 2017
Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthmaRui Zhu, Yanan Zheng, Nathanael L Dirks, et al.
Molecular Medicine (Cambridge, Mass.)|May 14, 2025
Targeting GPR84 to alleviate acute immune-mediated liver injuryYanan Zheng, Yumeng Wang, Yujie Xu, et al.
Cell Death & Disease|April 4, 2025
RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitinationChen Lu, Hongda Liu, Tianyu Liu, et al.
Cell Death Discovery|March 1, 2024
AIM2 regulates autophagy to mitigate oxidative stress in aged mice with acute liver injuryChao Hu, Mengjing Li, Yongzhen Chen, et al.
Eclinicalmedicine|November 3, 2025
Neoadjuvant FLOT versus SOX chemotherapy in locally advanced gastric cancer: secondary outcomes of a single-centre, open-label, randomised, exploratory phase 2 trialBirendra Kumar Sah, Zhenjia Yu, Benyan Zhang, et al.
Clinical Pharmacokinetics|January 20, 2012
A guide to rational dosing of monoclonal antibodiesShuang Bai, Karin Jorga, Yan Xin, et al.
Frontiers in Oncology|March 14, 2022
CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant ChemotherapyYong Chen, Wei Xu, Yan-Ling Li, et al.
Pageof 13